Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
LifeMD Inc (NASDAQ: LFMD) closed the day trading at $12.5 down -3.33% from the previous closing price of $12.93. In other words, the price has decreased by -$3.33 from its previous closing price. On the day, 0.9 million shares were traded. LFMD stock price reached its highest trading level at $13.09 during the session, while it also had its lowest trading level at $12.24.
Ratios:
For a better understanding of LFMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.75. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 0.82.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Schreiber Justin sold 25,000 shares for $13.38 per share. The transaction valued at 334,458 led to the insider holds 2,500,721 shares of the business.
Benathen Marc David sold 75,000 shares of LFMD for $981,945 on Jun 16 ’25. The Chief Financial Officer now owns 389,554 shares after completing the transaction at $13.09 per share. On Jun 17 ’25, another insider, Benathen Marc David, who serves as the Chief Financial Officer of the company, sold 50,000 shares for $14.01 each. As a result, the insider received 700,495 and left with 339,554 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 568094976 and an Enterprise Value of 611637824. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.43. Its current Enterprise Value per Revenue stands at 2.614 whereas that against EBITDA is -104.288.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.75, which has changed by 0.8910742 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.99. The 50-Day Moving Average of the stock is 14.52%, while the 200-Day Moving Average is calculated to be 84.19%.
Shares Statistics:
Over the past 3-months, LFMD traded about 1.97M shares per day on average, while over the past 10 days, LFMD traded about 2169800 shares per day. A total of 43.53M shares are outstanding, with a floating share count of 36.39M. Insiders hold about 19.93% of the company’s shares, while institutions hold 36.40% stake in the company. Shares short for LFMD as of 1749772800 were 3577104 with a Short Ratio of 1.82, compared to 1747267200 on 3864706. Therefore, it implies a Short% of Shares Outstanding of 3577104 and a Short% of Float of 9.54.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for LifeMD Inc (LFMD) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.16, with high estimates of $0.16 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.64 and $0.0 for the fiscal current year, implying an average EPS of $0.32. EPS for the following year is $0.6, with 2.0 analysts recommending between $0.95 and $0.25.
Revenue Estimates
7 analysts predict $66.44M in revenue for the current quarter. It ranges from a high estimate of $67.71M to a low estimate of $65.9M. As of the current estimate, LifeMD Inc’s year-ago sales were $50.66MFor the next quarter, 7 analysts are estimating revenue of $67.81M. There is a high estimate of $68.69M for the next quarter, whereas the lowest estimate is $67M.
A total of 7 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $273.23M, while the lowest revenue estimate was $266.8M, resulting in an average revenue estimate of $270.29M. In the same quarter a year ago, actual revenue was $212.45MBased on 7 analysts’ estimates, the company’s revenue will be $318.23M in the next fiscal year. The high estimate is $355M and the low estimate is $297.5M.
